Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  BioGaia AB (publ)    BIOG B   SE0000470395

BIOGAIA AB (PUBL)

(BIOG B)
  Report
Delayed Quote. Delayed NASDAQ OMX STOCKHOLM - 04/03 11:29:41 am
423.5 SEK   +0.24%
04/03BIOGAIA PUBL : Board of Directors revises the dividend proposal
PU
04/03BIOGAIA PUBL : Board of Directors revises the dividend proposal
AQ
03/30BIOGAIA PUBL : update concerning COVID-19 pandemic
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
03/30/2020 03/31/2020 04/01/2020 04/02/2020 04/03/2020 Date
427.5(c) 420(c) 418.5(c) 422.5(c) 423.5(c) Last
83 912 49 756 42 104 32 675 28 874 Volume
+16.01% -1.75% -0.36% +0.96% +0.24% Change
More quotes
Financials (SEK)
Sales 2020 889 M
EBIT 2020 294 M
Net income 2020 228 M
Finance 2020 313 M
Yield 2020 2,25%
Sales 2021 1 011 M
EBIT 2021 345 M
Net income 2021 266 M
Finance 2021 387 M
Yield 2021 2,67%
P/E ratio 2020 32,2x
P/E ratio 2021 27,6x
EV / Sales2020 7,89x
EV / Sales2021 6,87x
Capitalization 7 325 M
More Financials
Company
Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions... 
More about the company
Surperformance© ratings of BioGaia AB (publ)
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOGAIA AB (PUBL)
04/03BIOGAIA PUBL : Board of Directors revises the dividend proposal
PU
04/03BIOGAIA PUBL : Board of Directors revises the dividend proposal
AQ
03/30BIOGAIA PUBL : update concerning COVID-19 pandemic
AQ
03/26BIOGAIA PUBL : publishes annual report for 2019
AQ
03/16BIOGAIA PUBL : signs exclusive agreement in Argentina
AQ
02/12INFANT BACTERIAL THERAPEUTICS AB : Interim Management Statement, January 1 - Dec..
AQ
02/11BIOGAIA PUBL : oral health probiotic L. reuteri Prodentis reduces bleeding of th..
AQ
02/06BIOGAIA PUBL : AB – Year-end report 2019
PU
02/06BIOGAIA PUBL : AB – Year-end report 2019
PU
02/06BIOGAIA AB : - Year-end report 2019
AQ
2019BIOGAIA PUBL : signs exclusive agreement in Tunisia
AQ
2019INFANT BACTERIAL THERAPEUTICS AB : announces that the Nomination Committee is ap..
AQ
2019INFANT BACTERIAL THERAPEUTICS AB : (publ) announces that the Nomination Committe..
AQ
2019BIOGAIA PUBL : Nominating Committee for the AGM 7 May 2020
PU
2019BIOGAIA PUBL : New CFO to BioGaia
AQ
More news
News in other languages on BIOGAIA AB (PUBL)
2019BIOGAIA AB : Ex-dividend day for final dividend
2019BIOGAIA AB : Ex-dividend day for extraordinary dividend
2019BIOGAIA AB : Veröffentlichung des Quartalsumsatzes
2019BIOGAIA AB : publication du chiffre d'affaires trimestriel
2018BIOGAIA AB : Ex-dividend day for final dividend
More news
Chart BIOGAIA AB (PUBL)
Duration : Period :
BioGaia AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOGAIA AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 525,00  SEK
Last Close Price 422,50  SEK
Spread / Highest target 24,3%
Spread / Average Target 24,3%
Spread / Lowest Target 24,3%
EPS Revisions
Managers
NameTitle
Isabelle Valerie G. Ducellier Chief Executive Officer
Peter Michael Rothschild Chairman
Alexander Kotsinas Chief Financial Officer & Executive Vice President
Gianfranco Grompone Vice President-Discovery & Research
David E. R. Dangoor Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
BIOGAIA AB (PUBL)-0.24%733
BY-HEALTH CO., LTD.-0.94%3 752
BALCHEM CORPORATION-6.98%3 184
THE SIMPLY GOOD FOODS COMPANY-34.23%1 834
GRAPE KING BIO LTD0.00%886
BLACKMORES LIMITED0.00%778